Combined First Month Body Weight Loss and Development of Tolerance as Predictors of 6-Month Efficacy of Mazindol in Mild and Moderate Obese Subjects

The weight loss response to anti-obesity drugs is highly variable and poorly understood, which does not allow us to know, in advance, in which subjects the drug will be effective and in which it will not. The objective of this study was to explore the body weight reduction in kilograms in the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Huerta-Cruz, Juan Carlos, Rocha-González, Héctor Isaac, Kammar-García, Ashuin, Canizales-Quinteros, Samuel, Barranco-Garduño, Lina Marcela, Reyes-García, Juan Gerardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181115/
https://www.ncbi.nlm.nih.gov/pubmed/35683598
http://dx.doi.org/10.3390/jcm11113211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181115/
https://www.ncbi.nlm.nih.gov/pubmed/35683598
http://dx.doi.org/10.3390/jcm11113211

Ejemplares similares